José J. Escobar
About
In The Last Decade
José J. Escobar
11 papers receiving 182 citations
Hit Papers
Peers
Comparison fields: 5 of 50
- Hepatology 84
- Oral Surgery 46
- Epidemiology 45
- Surgery 32
- Oncology 29
Countries citing papers authored by José J. Escobar
This map shows the geographic impact of José J. Escobar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José J. Escobar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José J. Escobar more than expected).
Fields of papers citing papers by José J. Escobar
This network shows the impact of papers produced by José J. Escobar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José J. Escobar. The network helps show where José J. Escobar may publish in the future.
Co-authorship network of co-authors of José J. Escobar
This figure shows the co-authorship network connecting the top 25 collaborators of José J. Escobar. A scholar is included among the top collaborators of José J. Escobar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José J. Escobar. José J. Escobar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization. breakdown → | 93 |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 3 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 9 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 12 | |
| 14 | 23 | |
| 15 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.